December 21, 2017 / 1:40 PM / in 10 months

BRIEF-Moleculin Announces Polish Approval For Leukemia Clinical Trial

Dec 21 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ANNOUNCES POLISH APPROVAL FOR LEUKEMIA CLINICAL TRIAL

* MOLECULIN BIOTECH - ETHICS COMMITTEE IN POLAND HAS APPROVED COMPANY’S PHASE I/II CLINICAL TRIAL OF ANNAMYCIN FOR TREATMENT OF LEUKEMIA

* MOLECULIN BIOTECH INC - COMPANY EXPECTS FIRST PATIENT TO BE ENROLLED IN Q1 2018

* MOLECULIN BIOTECH - BELIEVES CLINICAL DATA PRODUCED IN POLAND WILL BE USEFUL IN INTERACTIONS WITH U.S. FDA, EUROPEAN MEDICINES AGENCY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below